Month: November 2015

Prevalence and factors associated with paroxysmal nocturnal hemoglobinuria presenting during pregnancy

    Research Article American Journal of BioMedicine Volume 3, Issue 11, pages 725-738 Received:June 25, 2015; accepted: October 02, 2015; published: November 24, 2015  Xin Wua, Ying Kanga, Jun Zhaoa, Huan Guoa, Yu Xieb, Xi Fenga, Xuan Dinga, Kun Leea Abstract Paroxysmal Nocturnal Hemoglobinuria (PNH) is a rare type of acquired hemolytic anemia […]

Prevalence and predictors oral human papillomavirus among HIV-positive women

The American Cancer Society (ACS) has developed guidelines for the use of the prophylactic human papillomavirus (HPV) vaccine for the prevention of cervical intraepithelial neoplasia and cervical cancer. Recent increases in incidence and survival of oropharyngeal cancers in the United States have been attributed to human papillomavirus (HPV) infection. The epidemiology of oral HPV among people who use drugs or HIV-positive is not well described. The objective of this study is to determinants of oral human papillomavirus (HPV) among HIV-positive women were investigated by testing them for HPV DNA. At interview information was obtained and a oropharngeal lavage sample was collected for polymerase chain reaction-based HPV testing.

Regorafenib in combination with 5-FU versus bevacizumab in advance relapsed colorectal cancer

Colorectal cancer remains one of the most deadly cancers in the U.S., researchers are making steady progress against this disease. New drugs allow people with even the most advanced metastatic disease tolive longer. We did a systematic review and meta-analysis to assess response to and survival after Regorafenib treatment in patients with advance relapsed colorectal carcer. We searched MEDLINE, Embase, Ovid, and Cochrane Central databases for published studies, and we used and other websites to find unpublished studies and conference abstracts.